SIGA logo

SIGA Technologies, Inc.

SIGA
Healthcare|Drug Manufacturers - Specialty & Generic|US
$3.10
+0.13 (+4.38%)
DCF Value
$8.71
Tangible Book / Share
$2.29
Cash / Share
$1.64

Analyst Consensus

Buy1 analysts
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0

Rating Trend

Recent Rating Actions

FirmActionRatingDate
WedbushmaintainOutperformNov 6, 2012

Earnings History

Report DateEPS ActualEPS Est.Revenue ActualRevenue Est.
Aug 6, 2026$0.17—$41.0M—
May 7, 2026$-0.05—$6.2M—
Mar 10, 2026$-0.08—$3.8M—
Nov 6, 2025$-0.09—$2.6M—
Aug 5, 2025$0.49—$81.1M—
May 8, 2025$-0.01—$7.0M—
Mar 11, 2025$0.63—$81.5M—
Nov 7, 2024$0.02—$10.0M—

News

SIGA to Host Business Update Call on November 9, 2026, Following Release of Third-Quarter 2026 Financial Results

NEW YORK, Oct. 29, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Monday, November 9, 2026. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer.

Oct 29, 2026globenewswire.com
SIGA Secures Contract Valued at Up to $15 Million from Canadian Department of National Defence to Purchase TPOXX®

Continues Canada's commitment to smallpox preparedness for the Canadian Armed Forces Continues Canada's commitment to smallpox preparedness for the Canadian Armed Forces

Oct 28, 2026globenewswire.com
Dimensional Fund Advisors LP Grows Stock Holdings in Siga Technologies Inc. $SIGA

Dimensional Fund Advisors LP grew its position in Siga Technologies Inc. (NASDAQ: SIGA) by 6.5% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,702,724 shares of the company's stock after buying an additional 165,930 shares during the quarter. Dimensional

Aug 9, 2026defenseworld.net